Ckd Bio (063160) — Cash Flow Reinvestment Rate

Latest as of June 2025: 1.13x

Ckd Bio (063160) has a Cash Flow Reinvestment Rate of 1.13x as of June 2025, reinvesting ₩3.62 Billion (capex ₩1.80 Billion plus investments ₩-1.82 Billion) from operating cash flow of ₩3.19 Billion. Explore Ckd Bio (063160) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.13x
(Capex + Investments) / Operating CF

Total Reinvested

₩3.62 Billion
Capex + Investments

Operating Cash Flow

₩3.19 Billion
KRW

Capital Expenditures

₩1.80 Billion
KRW

Ckd Bio Cash Flow Reinvestment Rate (2008–2024)

Historical reinvestment intensity for Ckd Bio across 14 annual periods. Also explore 063160 total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Ckd Bio (2008–2024)

Year-by-year capital reinvestment analysis for Ckd Bio. For live market cap and broader valuation context, see Ckd Bio market capitalisation.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.64x ₩9.04 Billion ₩14.03 Billion ₩4.28 Billion ▼ -95.0%
2020 12.78x ₩61.66 Billion ₩4.82 Billion ₩61.66 Billion ▲ +316.7%
2019 3.07x ₩52.12 Billion ₩16.99 Billion ₩47.31 Billion ▲ +173.3%
2018 1.12x ₩17.44 Billion ₩15.54 Billion ₩16.40 Billion ▲ +2.8%
2017 1.09x ₩22.32 Billion ₩20.45 Billion ₩9.67 Billion ▼ -22.6%
2016 1.41x ₩21.86 Billion ₩15.50 Billion ₩10.76 Billion ▲ +68.8%
2015 0.84x ₩11.98 Billion ₩14.34 Billion ₩11.91 Billion ▲ +174.2%
2014 0.30x ₩3.42 Billion ₩11.22 Billion ₩2.87 Billion ▼ -28.4%
2013 0.43x ₩4.65 Billion ₩10.92 Billion ₩4.10 Billion ▲ +30.8%
2012 0.33x ₩7.45 Billion ₩22.90 Billion ₩5.48 Billion ▼ -81.4%
2011 1.75x ₩22.68 Billion ₩12.96 Billion ₩22.09 Billion ▲ +106.3%
2010 0.85x ₩20.26 Billion ₩23.89 Billion ₩19.74 Billion ▲ +64.2%
2009 0.52x ₩13.72 Billion ₩26.57 Billion ₩13.53 Billion ▼ -25.5%
2008 0.69x ₩7.41 Billion ₩10.69 Billion ₩3.47 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow